Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Skin Neoplasms × sargramostim × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 33 Leukemia 31 Melanoma 26 Lymphoma, Non-Hodgkin 20 Lymphoma, Follicular 20 Leukemia, Lymphocytic, Chronic, B-Cell 20 Breast Neoplasms 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Lymphoma, Large B-Cell, Diffuse 17 Lymphoma, Mantle-Cell 16 Neuroblastoma 15 Lymphoma, Large-Cell, Immunoblastic 14 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13 Prostatic Neoplasms 12 Myelodysplastic Syndromes 12 Carcinoma, Non-Small-Cell Lung 12 Burkitt Lymphoma 12 Neoplasm Metastasis 11 Multiple Myeloma 11 Lung Neoplasms 11 Hodgkin Disease 11 Lymphoma, B-Cell, Marginal Zone 10 Leukemia, Myeloid, Chronic-Phase 10 Glioblastoma 10 Leukemia, Myeloid, Acute 9 Carcinoma, Ovarian Epithelial 9 Ovarian Neoplasms 8 Gliosarcoma 8 Fallopian Tube Neoplasms 7 Central Nervous System Neoplasms 7

Interventions

Nivolumab 12 Ipilimumab 10 pembrolizumab 8 Surveys and Questionnaires 6 Biopsy 6 cemiplimab 5 Radiotherapy 5 Blood Specimen Collection 5 aldesleukin 4 Photochemotherapy 4 Interleukin-2 4 Fluorouracil 4 Educational Status 4 avelumab 3 Vemurafenib 3 Temozolomide 3 Surgical Procedures, Operative 3 Sirolimus 3 Radiation 3 Petrolatum 3 Cyclophosphamide 3 Cetuximab 3 Aminolevulinic Acid 3 trametinib 2 sonidegib 2 fludarabine phosphate 2 fludarabine 2 dabrafenib 2 atezolizumab 2 Vinblastine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03282188 2018-05-04

REO13 Melanoma With of Without GM-CSF

University of Leeds

Phase 1/2 Withdrawn

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡